| Central Nervous System Lymphoma |
24.0% |
| Product Used For Unknown Indication |
19.2% |
| B-cell Lymphoma |
11.5% |
| Drug Use For Unknown Indication |
10.6% |
| Breast Cancer |
5.8% |
| Mantle Cell Lymphoma |
4.7% |
| Systemic Lupus Erythematosus |
4.5% |
| Lymphoma |
2.4% |
| Bone Marrow Conditioning Regimen |
2.1% |
| Drug Therapy |
1.8% |
| Peripheral T-cell Lymphoma Unspecified |
1.8% |
| Acute Lymphocytic Leukaemia |
1.7% |
| Nodular (Follicular) Lymphoma |
1.7% |
| Plasma Cell Myeloma |
1.5% |
| Hodgkin's Disease |
1.4% |
| Angioimmunoblastic T-cell Lymphoma |
1.3% |
| Granulomatosis With Polyangiitis |
1.1% |
| T-cell Lymphoma |
1.1% |
| Premedication |
0.9% |
| Small Cell Lung Cancer |
0.9% |
